Towerpoint Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Towerpoint Wealth's ABBV Position: Q3 2026 in Review
Towerpoint Wealth held its AbbVie (ABBV) position steady in Q3 2026 at 4,871 shares worth $1.27M. The position accounts for 0.45% of the portfolio, ranked #43.
Towerpoint Wealth first reported a position in ABBV in Q1 2021 and has held it in 23 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Towerpoint Wealth held 4,871 shares of AbbVie worth $1.27M as of Q3 2026.
- Towerpoint Wealth left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.45% of Towerpoint Wealth's portfolio in Q3 2026, its #43 holding.
- Towerpoint Wealth first reported a position in AbbVie in Q1 2021 and has held it in 23 quarters since.
- 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Towerpoint Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.